“Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis over 3 Years from Three Phase 3, Randomized, Placebo-Controlled Studies”, J of Skin, vol. 4, no. 1, p. S5, Jan. 2020, Accessed: Apr. 19, 2025. [Online]. Available: https://skin.dermsquared.com/skin/article/view/809